The severity of executive dysfunction among different PD-MCI subtypes

被引:3
|
作者
Kormas, Constantinos [1 ]
Zalonis, Ioannis [1 ]
Evdokimidis, Ioannis [1 ]
Kapaki, Elisabeth [1 ]
Potagas, Constantin [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, 72-74 Vas Sophias Ave, Athens 11528, Greece
关键词
Executive functions; inhibitory control; mental flexibility; mild cognitive impairment; Parkinson's disease; MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; NORMATIVE DATA; POPULATION; DEMENTIA;
D O I
10.1080/23279095.2020.1786832
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim to examine the severity of executive dysfunction among different Parkinson's disease (PD)-mild cognitive impairment (MCI) subtypes in the early stages of the disease. The final sample consisted of 65 patients with mild PD progression. Based on neuropsychological measures, our sample was categorized into three PD-MCI subtypes: (1) PD-MCI executive group (n = 24), (2) PD-MCI executive plus memory group (n = 22), and (3) PD-MCI executive plus visuospatial group (n = 19). Patients' executive functions were evaluated with the Trail Making Test-Part B (TMT-B) and Stroop Neuropsychological Screening Test (SNST) for mental flexibility and inhibitory control, respectively. One-way ANOVA results indicated significant differences among the three subgroups on TMT-B and SNST performance.Post hocTukey honestly significant different (HSD) tests revealed that the PD-MCI executive plus visuospatial group had lower performances on both executive measures than the other two groups. Contrastingly, no significant differences were observed between the PD-MCI executive group and PD-MCI executive plus memory group. Our results indicated that the severity of executive dysfunction varies across different PD-MCI subtypes. These findings are discussed within the framework of the dual syndrome hypothesis and highlight the utility of determination of executive impairment severity for effective clinical management of patients with PD.
引用
收藏
页码:546 / 550
页数:5
相关论文
共 50 条
  • [31] Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline
    Jones, Jacob D.
    Rivas, Rhiannon
    Luna, Kenya
    Ryczek, Cameron A.
    Thomas, Kelsey R.
    PARKINSONISM & RELATED DISORDERS, 2023, 106
  • [32] Visuo-spatial N-back test is useful for the assessment of the screening of PD-MCI
    Shimizu, Y.
    Kawashima, S.
    Horiba, M.
    Ueki, Y.
    Mizutani, J.
    Matsukawa, N.
    Wada, I.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 734 - 734
  • [33] Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
    Boel, Judith A.
    Bie, Rob M. A.
    Schmand, Ben A.
    Dalrymple-Alford, John C.
    Marras, Connie
    Adler, Charles H.
    Goldman, Jennifer G.
    Troster, Alexander, I
    Burn, David J.
    Litvan, Irene
    Geurtsen, Gert J.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (04): : 479 - 483
  • [34] Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
    Cammisuli, Davide Maria
    Cammisuli, Salvatore Massimiliano
    Fusi, Jonathan
    Franzoni, Ferdinando
    Pruneti, Carlo
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [35] MDS Task Force on Mild Cognitive Impairment in Parkinson's Disease: Critical Review of PD-MCI
    Litvan, Irene
    Aarsland, Dag
    Adler, Charles H.
    Goldman, Jennifer G.
    Kulisevsky, Jaime
    Mollenhauer, Brit
    Rodriguez-Oroz, Maria C.
    Troester, Alexander I.
    Weintraub, Daniel
    MOVEMENT DISORDERS, 2011, 26 (10) : 1814 - 1824
  • [36] Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes
    Jones, Jacob D.
    Uribe, Carmen
    Bunch, Joseph
    Thomas, Kelsey R.
    JOURNAL OF NEUROLOGY, 2021, 268 (01) : 337 - 345
  • [37] Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes
    Jacob D. Jones
    Carmen Uribe
    Joseph Bunch
    Kelsey R. Thomas
    Journal of Neurology, 2021, 268 : 337 - 345
  • [38] Measuring cognitive decline in PD-MCI patients with high level education: Do we have the appropriate tools?
    Rosenblum, S.
    Mentzer, L.
    Richardson, A.
    Nevo, T.
    Meyer, S.
    Gemerman, N.
    Hassin-Baer, S.
    Israeli-Korn, S.
    Fay-Karmon, T.
    Livneh, V.
    Yahalom, G.
    MOVEMENT DISORDERS, 2019, 34 : S709 - S709
  • [39] Blood Pressure Profile of PD-MCI and PDD in Parkinson's disease (PD) Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
    Al Jody, A.
    Tiksnadi, A.
    Tunjungsari, D.
    MOVEMENT DISORDERS, 2024, 39 : S134 - S135
  • [40] The prevalence and nature of mild cognitive impairment in Parkinson's disease (PD-MCI) identified using automated cognitive tests
    Wesnes, K. A.
    Burn, D. J.
    MOVEMENT DISORDERS, 2013, 28 : S201 - S201